Filing Details
- Accession Number:
- 0001209191-21-066289
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-23 07:46:26
- Reporting Period:
- 2021-11-22
- Accepted Time:
- 2021-11-23 07:46:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1287098 | Maxcyte Inc. | MXCT | Biological Products, (No Disgnostic Substances) (2836) | MA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1021015 | Richard Douglas | C/O Maxcyte, Inc. 22 Firstfield Road, Suite 110 Gaithersburg MD 20878 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-22 | 20,000 | $11.12 | 20,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Reporting Person purchased the securities on the open market at purchase prices ranging from $11.01 to $11.16 per share, with a weighted average purchase price of $11.12 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
